Skip to main content
. 2018 Aug 30;18:858. doi: 10.1186/s12885-018-4759-x

Table 3.

% cancers of the vulva having radiotherapy (and odds ratios for radiotherapy) as part of the primary course of treatment; Australian major public hospitals, 1984–2016 diagnoses

Number of cases Radiotherapy (%) p value*
Mann-Whitney or Pearson Chi-square
Odds ratiosa - adjusted (95% CIs)
All (n = 383) 26.4
Age at diagnosis (yrs.):
 < 50 (n = 56) 30.4 MW p = 0.098 1.00
 50–69 (n = 100) 25.0 0.41 (0.16, 1.06)
 70–79 (n = 113) 35.4 0.70 (0.28, 1.75)
 80+ (n = 114) 16.7 0.18 (0.06, 0.48)
FIGO stage:
 I (n = 167) 7.2 MW p < 0.001 (excluding UK) 1.00
 II (n = 103) 24.3 5.97 (2.60, 13.72)
 III (n = 68) 66.2 32.11 (13.24, 77.85)
 IV (n = 29) 58.6 25.37 (8.54, 75.37)
 (Unknown (n = 16)) (12.5) (1.81 (0.33, 10.05))
Differentiation:
 Well (n = 102) 11.8 MW p = 0.001 (excluding UK) 1.00
 Moderate (n = 136) 28.7 1.87 (0.81, 4.33)
 Poorly/undifferentiated (n = 75) 42.7 2.67 (1.06, 6.68)
 (Unknown) (n = 70) (25.7) (2.18 (0.80, 5.98))
Histology:
 Squamous cell carcinoma (n = 341) 26.4 p = 0.978 1.00
 Other (n = 42) 26.2 0.87 (0.32, 2.36)
Socioeconomic (SEIFA):
 Low (n = 138) 26.8 MW p = 0.565 1.00
 Low/med (n = 75) 17.3 0.63 (0.25, 1.56)
 Med/high (n = 77) 32.5 1.60 (0.74, 3.45)
 High (n = 93) 28.0 0.77 (0.36, 1.64)
Geographic remoteness:
 Low (n = 314) 25.5 MW p = 0.380 1.00
 Moderate (n = 45) 28.9 2.29 (0.53, 3.13)
 High (n = 24) 33.3 1.38 (0.44, 4.36)
Diagnostic period (calendar years.):
 1984–99 (n = 199) 21.1 p = 0.015 1.00
 2000–16 (n = 184) 32.1 1.72 (0.93, 3.15)

*Derived from Mann-Whitney (ordinal) or Pearson chi-square (1d.f.) (binary)

aDerived from multiple logistic regression, adjusting for other variables in the Table